Farther Finance Advisors LLC Boosts Stake in Humana Inc. (NYSE:HUM)

Farther Finance Advisors LLC lifted its holdings in Humana Inc. (NYSE:HUM) by 4.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 2,103 shares of the insurance provider’s stock after purchasing an additional 81 shares during the quarter. Farther Finance Advisors LLC’s holdings in Humana were worth $533,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the business. FPC Investment Advisory Inc. purchased a new stake in Humana during the fourth quarter worth $27,000. Centricity Wealth Management LLC purchased a new stake in Humana during the fourth quarter worth $30,000. OFI Invest Asset Management purchased a new stake in Humana during the fourth quarter worth $33,000. Atwood & Palmer Inc. boosted its position in Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 60 shares in the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in Humana during the fourth quarter worth $49,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have commented on HUM shares. Morgan Stanley decreased their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Piper Sandler boosted their target price on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Royal Bank of Canada restated an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Finally, StockNews.com downgraded Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Nineteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, Humana presently has a consensus rating of “Hold” and an average target price of $285.68.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.32% of the company’s stock.

Humana Stock Up 0.5 %

Shares of NYSE:HUM opened at $253.11 on Monday. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The stock has a 50-day simple moving average of $271.37 and a 200-day simple moving average of $279.50. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $30.55 billion, a P/E ratio of 25.44, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is presently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.